# Endurant Capital Management LP

> Institutional holdings reported to the SEC as of Q4 2023 on Form 13F. CIK 1633055. Source: https://holderbook.com/funds/1633055-endurant-capital-management-lp/

- Reported value: $17.4M
- Positions: 25
- Weight of the ten largest: 70.1%
- Filed: 2024-02-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| BOSTON SCIENTIFIC CORP | [BSX](https://holderbook.com/stocks/BSX/) | $2.3M | 39,108 | 13.0% | 3 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $2.0M | 3,794 | 11.5% | 2 |
| AXONICS INC | [AXNX](https://holderbook.com/stocks/AXNX/) | $1.5M | 24,871 | 8.9% | 1 |
| ELEVANCE HEALTH INC FORMERLY | [ELV](https://holderbook.com/stocks/ELV/) | $1.2M | 2,627 | 7.1% | 6 |
| ICON PUB LTD CO | [ICLR](https://holderbook.com/stocks/ICLR/) | $1.0M | 3,659 | 5.9% | 1 |
| LABORATORY CORP AMER HLDGS | [LH](https://holderbook.com/stocks/LH/) | $905.5K | 3,984 | 5.2% | 1 |
| ENCOMPASS HEALTH CORP | [EHC](https://holderbook.com/stocks/EHC/) | $858.7K | 12,870 | 4.9% | 1 |
| INSULET CORP | [PODD](https://holderbook.com/stocks/PODD/) | $847.5K | 3,906 | 4.9% | 2 |
| HOLOGIC INC | [HOLX](https://holderbook.com/stocks/HOLX/) | $831.0K | 11,631 | 4.8% | 2 |
| ZIMMER BIOMET HOLDINGS INC | [ZBH](https://holderbook.com/stocks/ZBH/) | $687.1K | 5,646 | 3.9% | 2 |
| AVANTOR INC | [AVTR](https://holderbook.com/stocks/AVTR/) | $561.6K | 24,598 | 3.2% | 2 |
| TENET HEALTHCARE CORP | [THC](https://holderbook.com/stocks/THC/) | $551.9K | 7,303 | 3.2% | 11 |
| PFIZER INC | [PFE](https://holderbook.com/stocks/PFE/) | $454.6K | 15,790 | 2.6% | 1 |
| BIOMARIN PHARMACEUTICAL INC | [BMRN](https://holderbook.com/stocks/BMRN/) | $448.4K | 4,650 | 2.6% | 7 |
| ORTHOPEDIATRICS CORP | [KIDS](https://holderbook.com/stocks/KIDS/) | $436.5K | 13,428 | 2.5% | 3 |
| THE CIGNA GROUP | [CI](https://holderbook.com/stocks/CI/) | $414.4K | 1,384 | 2.4% | 11 |
| QUIDELORTHO CORP | [QDEL](https://holderbook.com/stocks/QDEL/) | $379.3K | 5,147 | 2.2% | 2 |
| COOPER COS INC | [COO](https://holderbook.com/stocks/COO/) | $373.9K | 988 | 2.1% | 2 |
| SABRA HEALTH CARE REIT INC | [SBRA](https://holderbook.com/stocks/SBRA/) | $285.6K | 20,017 | 1.6% | 2 |
| AGILENT TECHNOLOGIES INC | [A](https://holderbook.com/stocks/A/) | $264.2K | 1,900 | 1.5% | 1 |
| FORTREA HLDGS INC | [FTRE](https://holderbook.com/stocks/FTRE/) | $243.9K | 6,988 | 1.4% | 1 |
| QIAGEN NV | [QGEN](https://holderbook.com/stocks/QGEN/) | $226.7K | 5,219 | 1.3% | 1 |
| HUMANA INC | [HUM](https://holderbook.com/stocks/HUM/) | $214.7K | 469 | 1.2% | 2 |
| CENCORA INC | [COR](https://holderbook.com/stocks/COR/) | $203.3K | 990 | 1.2% | 2 |
| ACLARIS THERAPEUTICS INC | [ACRS](https://holderbook.com/stocks/ACRS/) | $155.8K | 148,400 | 0.9% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q4 2023 | +7.2% | +11.2% | -4.0% | 100% |
| Q3 2023 | -7.8% | -3.6% | -4.2% | 91% |
| Q2 2023 | -0.1% | +8.3% | -8.4% | 100% |
| Q1 2023 | -4.5% | +7.0% | -11.6% | 75% |
| Q4 2022 | +4.5% | +7.1% | -2.5% | 81% |
| Q3 2022 | -4.2% | -5.3% | +1.1% | 75% |
| Q2 2022 | -12.1% | -16.5% | +4.3% | 82% |
| Q1 2022 | -7.7% | -4.9% | -2.8% | 80% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2023 | $17.4M | 25 |
| Q3 2023 | $111.3M | 43 |
| Q2 2023 | $114.5M | 33 |
| Q1 2023 | $194.7M | 49 |
| Q4 2022 | $246.3M | 55 |
| Q3 2022 | $307.0M | 49 |
| Q2 2022 | $285.0M | 49 |
| Q1 2022 | $379.6M | 62 |
| Q4 2021 | $414.3M | 66 |
| Q3 2021 | $439.1M | 53 |
| Q2 2021 | $363.8M | 57 |
| Q1 2021 | $383.5M | 61 |